Marwa A. Fouad

Kasr El Aini Street
Cairo, C 11562, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Pharmacokinetic assessment and metabolic stability of a novel multi-targeted Clk/Dyrk inhibitor using a validated LC-MS/MS method: In vitro and in vivo insights.

Pharmacokinetic assessment and metabolic stability of a novel multi-targeted Clk/Dyrk inhibitor using a validated LC-MS/MS method: In vitro and in vivo insights.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Published: October 12, 2025

Design and synthesis of new phosphazine and triazole derivatives for treatment of Alzheimer's disease: modulating ROS/JNK and Wnt/β-catenin signaling pathways.

Design and synthesis of new phosphazine and triazole derivatives for treatment of Alzheimer's disease: modulating ROS/JNK and Wnt/β-catenin signaling pathways.

Journal: RSC advances

Published: October 05, 2025

Recent advances in saponin-lipase-microbiota triad effect on obesity management, a comprehensive review.

Recent advances in saponin-lipase-microbiota triad effect on obesity management, a comprehensive review.

Journal: European journal of medicinal chemistry

Published: August 08, 2025

Design and development of potent roflumilast analogues targeting PDE-4B: selectivity and pharmacokinetic insights.

Design and development of potent roflumilast analogues targeting PDE-4B: selectivity and pharmacokinetic insights.

Journal: Bioorganic chemistry

Published: July 25, 2025

Quinolone as a Privileged Scaffold: A Brief Overview on Early Classical and Recent Advanced Synthetic Pathways, Innovative Neuroprotective Potential, and Structure-Activity Relationships.

Quinolone as a Privileged Scaffold: A Brief Overview on Early Classical and Recent Advanced Synthetic Pathways, Innovative Neuroprotective Potential, and Structure-Activity Relationships.

Journal: Drug development research

Published: April 26, 2025

Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies.

Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies.

Journal: Scientific reports

Published: March 17, 2025

Rationale design and synthesis of new roflumilast analogues as preferential selective and potent PDE-4B inhibitors.

Rationale design and synthesis of new roflumilast analogues as preferential selective and potent PDE-4B inhibitors.

Journal: Bioorganic chemistry

Published: August 18, 2024

Farnesyl pyrophosphate synthase inhibitors with antiosteoporosis efficacy in ovariectomized rats: A mixed binding approach beyond bisphosphonates.

Farnesyl pyrophosphate synthase inhibitors with antiosteoporosis efficacy in ovariectomized rats: A mixed binding approach beyond bisphosphonates.

Journal: European journal of medicinal chemistry

Published: May 09, 2024

Correlating physico-chemical properties of analytes with Hansen solubility parameters of solvents using machine learning algorithm for predicting suitable extraction solvent.

Correlating physico-chemical properties of analytes with Hansen solubility parameters of solvents using machine learning algorithm for predicting suitable extraction solvent.

Journal: Scientific reports

Published: April 16, 2024

Probing benzenesulfonamide-thiazolidinone hybrids as multitarget directed ligands for efficient control of type 2 diabetes mellitus through targeting the enzymes: α-glucosidase and carbonic anhydrase II.

Probing benzenesulfonamide-thiazolidinone hybrids as multitarget directed ligands for efficient control of type 2 diabetes mellitus through targeting the enzymes: α-glucosidase and carbonic anhydrase II.

Journal: European journal of medicinal chemistry

Published: January 21, 2024

Discovery of novel quinolin-2-one derivatives as potential GSK-3β inhibitors for treatment of Alzheimer's disease: Pharmacophore-based design, preliminary SAR, in vitro and in vivo biological evaluation.

Discovery of novel quinolin-2-one derivatives as potential GSK-3β inhibitors for treatment of Alzheimer's disease: Pharmacophore-based design, preliminary SAR, in vitro and in vivo biological evaluation.

Journal: Bioorganic chemistry

Published: January 17, 2024

Exploring new quinazolin-4(3H)-one derivatives as CDK2 inhibitors: Design, synthesis, and anticancer evaluation.

Exploring new quinazolin-4(3H)-one derivatives as CDK2 inhibitors: Design, synthesis, and anticancer evaluation.

Journal: Drug development research

Published: November 20, 2023

Showing 1-12 of 60

Last Updated: 09/26/2026